The award, which was established by Chawla Hope Initiatives under the direction of 3+ year survivor Prem Chawla, is intended for the research lab and its leader showing the most progress in lung cancer research in a particular year. The purpose of this award is to provide funding for research and to recognize the demonstrated excellence of research labs seeking to develop novel treatment options for lung cancer survivors. As Mr. Chawla noted, “Many survivors are developing resistance to available treatments, and so these doctors are making a valiant effort to overcome this challenge and take us to the next level of progress.”
This year, The Caine Halter Fund for Lung Cancer Research begins sponsorship of the Hope Now Award, which will hereafter be known as the Caine Halter Hope Now Award.
 This year’s Caine Halter Hope Now Award goes to
Dr. Eric Haura, M.D.,
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
Dr. Haura is studying how mutated proteins in lung cells cause cancer. He is developing new drugs that will kill cancer cells by specifically blocking the function of these abnormal proteins.
In particular, his work continues to focus on tyrosine kinase signaling pathways in lung cancer. The main focus is on STAT signaling pathways as well as SRC pathways, and preclinical and clinical studies are underway to better understand how inhibitors of these pathways may kill lung cancer cells. Finally, he and his team are invested in applying systems biology to understanding cancer signaling networks and how drugs impact these networks.
Caine Halter was committed to making a difference in the world, including by providing hope to others for survival of lung cancer. We congratulate Dr. Haura and his team, and thank them for all they do to increase hope in the fight against lung cancer!
|
